Healthcare Equipment and Supplies
Company Overview of IMCOR Pharmaceutical Co.
IMCOR Pharmaceutical Co. does not have significant operations. It owns Imagent, an ultrasound imaging contrast agent for use in patients with suboptimal echocardiograms. Prior to April 2005, the company engaged in the development and marketing of medical imaging pharmaceutical products. IMCOR was founded in 1994 as MT Financial Group, Inc. and changed its name to Photogen Technologies, Inc. in 1997. Later, it changed its name to IMCOR Pharmaceutical Co. in 2004. The company is headquartered in San Diego, California.
4660 La Jolla Drive
San Diego, CA 92122
Founded in 1994
Key Executives for IMCOR Pharmaceutical Co.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact IMCOR Pharmaceutical Co., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.